Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
aerosolized, American, amylodotic, amyloid, amyloidotic, antiviral, arisen, Asian, attenuated, auction, augmenting, autonomic, biomarker, bioprocessing, Boston, bowel, California, cardiomyopathy, carrier, China, circulation, clarify, cleaving, cognitive, Cook, correlate, Cubist, DC, defeased, diflunisal, digit, diminished, discontinued, disruption, downturn, drawn, enormously, escalation, evidenced, exacerbate, Exhibit, exploitation, extrahepatic, FAC, fallen, FAP, Farrell, FoldRx, Francisco, Giordano, Gretchen, GSK, Hakko, hereditary, hired, hormone, hTTR, includingNature, insignificant, invasive, irrevocable, Jack, JDCC, journalsNature, Jr, JRCC, JTTC, kilogram, Kirby, Kirin, knockdown, Koch, Kyowa, leader, Li, maximize, MDRNA, meaningful, misfolding, morbidity, NE, nerve, Neurological, neuropathy, North, notably, notwithstanding, NZ, onset, orphan, overturned, overturning, Pachuk, Paradoxically, partnership, peripheral, plasma, polyneuropathy, preexisting, promissory, quicker, ramping, ready, recast, reevaluate, resource, resubmit, retention, retinol, RNAa, Room, RU, Russia, Salk, San, Satishchandran, Schmidt, Semple, severest, SG, shortage, similarly, simultaneously, slightly, solid, Stone, Stroke, subset, supplemental, Takeda, territory, thereon, thereto, thereunder, thyroid, tied, tightening, timeline, tool, top, transgenic, transthyretin, TTR, TTRin, unadjusted, unappealable, understated, undruggable, unobservable, variant, vector, view, vigorously, vitro, Vytorin, warrant, Wheeler, wind, ZA
Removed:
addendum, affiliated, assembly, Australian, behavior, branched, building, capable, CF, CFFT, choice, CNS, coded, collateralized, comparing, confirm, consecutively, considerably, Convention, create, cut, cutting, cystic, CytRx, deduced, degradation, deoxyribonucleic, destroying, destruction, diagnostic, displaced, dispose, divisional, driven, easily, encode, figure, financed, Garching, gave, generation, great, handed, helix, intermediary, intertwined, IP, monitoring, narrowly, Nastech, neuronal, nonrefundable, nose, ocular, opposite, optimization, pair, pairing, patented, phenomenon, physical, producing, proved, purpose, quantity, reaching, region, repaid, repeated, Repetitive, replaced, revoke, ribonucleic, RNAitm, rule, scan, screening, selective, settled, shorter, sophisticated, step, strand, stretch, strict, sublicense, substance, surface, tangible, theory, thisForm, thousand, undergo, unpaired, unstable, Utility, validation, vital, withhold
Filing tables
Filing exhibits
- 10-K Annual report
- 10.23 EX-10.23 Research Collaboration and License Agreement
- 10.26 EX-10.26 License and Collaboration Agreement
- 21.1 EX-21.1 Subsidiaries of the Registrant
- 23.1 EX-23.1 Consent of Pricewaterhousecoopers LLP
- 23.2 EX-23.2 Consent of Ernst & Young LLP
- 31.1 EX-31.1 Section 302 Certification of the Chief Executive Officer
- 31.2 EX-31.2 Section 302 Certification of the Vice President of Finance and Treasurer
- 32.1 EX-32.1 Section 906 Certification of the Chief Executive Officer
- 32.2 EX-32.2 Section 906 Certification of the Vice President of Finance and Treasurer
- 99.1 EX-99.1 Regulus Therapeutics LLC Financial Statements
Related press release
ALNY similar filings
External links